脂肪性肝病与事件SSc风险之间的关联:全国范围的队列研究

相关实验视频

Updated: Jan 18, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

717

Oh Chan Kwon1, Kyu-Na Lee2, Kyungdo Han3

  • 1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

Rheumatology (Oxford, England)
|May 24, 2025
PubMed
概括

脂肪性肝病 (SLD) 与患有全身性硬化症 (SSc) 的风险更高有关. 管理SLD,特别是与酒精有关的肝病,可能会减少SSc的发病率.

关键词:
这就是为什么SSc SSc抗核抗体是一种抗核抗体.危险的风险 危险的风险脂肪性肝病肝脏疾病.

更多相关视频

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.6K
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

5.4K

相关概念视频

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K